JP2004000208A5 - - Google Patents

Download PDF

Info

Publication number
JP2004000208A5
JP2004000208A5 JP2003119118A JP2003119118A JP2004000208A5 JP 2004000208 A5 JP2004000208 A5 JP 2004000208A5 JP 2003119118 A JP2003119118 A JP 2003119118A JP 2003119118 A JP2003119118 A JP 2003119118A JP 2004000208 A5 JP2004000208 A5 JP 2004000208A5
Authority
JP
Japan
Prior art keywords
seq
cerebral
spinal cord
sequence
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003119118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004000208A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2004000208A publication Critical patent/JP2004000208A/ja
Publication of JP2004000208A5 publication Critical patent/JP2004000208A5/ja
Pending legal-status Critical Current

Links

JP2003119118A 1996-03-11 2003-04-23 ヒトビクニン Pending JP2004000208A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1310696P 1996-03-11 1996-03-11
US1979396P 1996-06-14 1996-06-14
US72525196A 1996-10-04 1996-10-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP53280497A Division JP3469584B2 (ja) 1996-03-11 1997-03-10 ヒト ビクニン

Publications (2)

Publication Number Publication Date
JP2004000208A JP2004000208A (ja) 2004-01-08
JP2004000208A5 true JP2004000208A5 (https=) 2005-02-17

Family

ID=27359773

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53280497A Expired - Fee Related JP3469584B2 (ja) 1996-03-11 1997-03-10 ヒト ビクニン
JP2003119118A Pending JP2004000208A (ja) 1996-03-11 2003-04-23 ヒトビクニン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP53280497A Expired - Fee Related JP3469584B2 (ja) 1996-03-11 1997-03-10 ヒト ビクニン

Country Status (27)

Country Link
US (3) US6583108B1 (https=)
EP (1) EP0891426B1 (https=)
JP (2) JP3469584B2 (https=)
KR (1) KR100356956B1 (https=)
AR (3) AR006188A1 (https=)
AT (1) ATE328083T1 (https=)
AU (1) AU716923B2 (https=)
BR (1) BR9708021A (https=)
CA (1) CA2247888A1 (https=)
CO (1) CO4600683A1 (https=)
DE (1) DE69735996T2 (https=)
DK (1) DK0891426T3 (https=)
ES (1) ES2263174T3 (https=)
HR (1) HRP970144B1 (https=)
HU (1) HU226419B1 (https=)
ID (1) ID16224A (https=)
IL (1) IL126115A (https=)
IN (1) IN192874B (https=)
MY (1) MY120693A (https=)
NZ (1) NZ331540A (https=)
PA (1) PA8426301A1 (https=)
PL (1) PL188387B1 (https=)
PT (1) PT891426E (https=)
SV (1) SV1997000018A (https=)
TR (1) TR199801794T2 (https=)
WO (1) WO1997033996A2 (https=)
YU (1) YU8997A (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
DE69632435T2 (de) * 1995-07-24 2005-05-12 Mitsubishi Chemical Corp. Inhibitor des Hepatozytwachstumsfaktoraktivators
JP3469584B2 (ja) 1996-03-11 2003-11-25 バイエル コーポレイション ヒト ビクニン
JP2001504709A (ja) 1997-01-31 2001-04-10 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 組織因子経路インヒビター３
ES2209542T3 (es) * 1998-12-22 2004-06-16 Bayer Aktiengesellschaft Metodo para acelerar la velocidad de eliminacion mucociliar usando un inhibidor de serinproteasa de tipo kunitz.
AU3731400A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
US20040235715A1 (en) * 1999-11-12 2004-11-25 Bayer Corporation Method of producing glycosylated bikunin
IL140993A0 (en) 2000-05-15 2002-02-10 Bayer Ag Trypsin substrate and diagnostic device, and method of using same
IL140994A (en) * 2000-05-15 2005-12-18 Bayer Ag Urinary trypsin inhibitor assay containing a chelating agent
US6955921B2 (en) * 2001-04-30 2005-10-18 Bayer Corporation Trypsin substrate and diagnostic device, and method of using same
WO2003040330A2 (en) * 2001-11-05 2003-05-15 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
ES2348230T3 (es) 2002-06-07 2010-12-01 Dyax Corp. Prevención y reducción de la isquemia.
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
WO2004060403A2 (en) 2003-01-06 2004-07-22 Angiochem Inc. Aprotinin and anglos as carriers across the blood-brain barrier
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
JP2007518426A (ja) * 2003-10-10 2007-07-12 マルチセル テクノロジーズ、インコーポレイテッド 不死化肝細胞
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
EP1586587A1 (en) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Compositions and methods for detecting angiogenesis
WO2005119524A2 (en) 2004-06-04 2005-12-15 Therasense, Inc. Diabetes care host-client architecture and data management system
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
RU2408605C2 (ru) * 2005-02-18 2011-01-10 Анджиокем Инк. Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат
WO2007011693A2 (en) * 2005-07-14 2007-01-25 Medistem Laboratories, Inc. Compositions of placentally-derived stem cells for the treatment of cancer
ES2744225T3 (es) 2005-07-15 2020-02-24 Angiochem Inc Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
US8093017B2 (en) * 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
PL1981519T3 (pl) * 2005-12-29 2018-07-31 Dyax Corp. Hamowanie proteaz
CA2663545A1 (en) * 2006-09-19 2008-03-27 Phylogica Limited Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
US20100063146A1 (en) * 2006-11-07 2010-03-11 Medof M Edward Method for treating disorders related to complement activation
WO2008077478A1 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8822409B2 (en) * 2007-06-20 2014-09-02 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
US20090075887A1 (en) * 2007-08-21 2009-03-19 Genzyme Corporation Treatment with Kallikrein Inhibitors
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
MX355683B (es) * 2008-04-18 2018-04-26 Angiochem Inc Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
WO2010043049A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
CA2740316A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
US8853353B2 (en) 2008-12-17 2014-10-07 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
US8637454B2 (en) 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
MX2011011023A (es) 2009-04-20 2012-01-20 Angiochem Inc Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
SMT201800552T1 (it) 2010-01-06 2018-11-09 Dyax Corp Proteine che legano la callicreina plasmatica
EP2371857A1 (en) * 2010-04-01 2011-10-05 CSL Behring GmbH Factor XII inhibitors for treating interstitial lung disease
KR102320178B1 (ko) 2011-01-06 2021-11-02 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
WO2012178102A2 (en) 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
CA2896951A1 (en) 2012-01-10 2013-07-18 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
JP2015526434A (ja) 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
PL3110434T3 (pl) 2014-02-24 2019-01-31 Takeda Gmbh Białka fuzyjne uti
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
EP3307326B9 (en) 2015-06-15 2021-02-24 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
EP3387018A1 (en) 2015-12-11 2018-10-17 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP4090427A1 (en) 2020-01-13 2022-11-23 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack
US11725043B2 (en) 2020-03-05 2023-08-15 DiaMedica USA Inc. Ulinastatin polypeptides

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en) 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US5663143A (en) 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DK0401508T3 (da) * 1989-05-13 1995-05-15 Bayer Ag Proteaseinhibitorer, fremgangsmåde til deres fremstilling samt lægemidler med indhold deraf
DK408089D0 (da) 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
DE69117545T2 (de) 1990-01-25 1996-10-31 Univ Washington Faktor X-LACI-Hybridprotein
AU1581692A (en) 1991-03-01 1992-10-06 Protein Engineering Corporation Inhibitors of human neutrophil elastase and human cathepsin g
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
IL104325A (en) 1992-01-07 2000-10-31 Novo Nordisk As Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
IL104326A0 (en) 1992-01-07 1993-05-13 Novo Nordisk As Variant of human kunitz-type protease inhibitor
JPH07509229A (ja) 1992-07-13 1995-10-12 コルバス・インターナショナル、インコーポレイテッド ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
US5436153A (en) 1992-12-02 1995-07-25 Sprecher; Cindy A. Human amyloid protein precursor homolog and Kunitz-type inhibitor
WO1994012637A2 (en) 1992-12-02 1994-06-09 Zymogenetics, Inc. Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2769083B2 (ja) 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en) 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
WO1995021601A2 (en) 1994-01-11 1995-08-17 Protein Engineering Corporation Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
ATE277081T1 (de) 1994-01-11 2004-10-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
US5795954A (en) 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
WO1996003503A1 (en) 1994-07-21 1996-02-08 The Green Cross Corporation Process for producing urinary trypsin inhibitor and domains thereof, novel polypeptide related to the both, and process for producing the polypeptide
US5541228A (en) * 1994-10-14 1996-07-30 Bristol-Myers Squibb Co. Melatonergic agents
KR19990008458A (ko) 1995-05-08 1999-01-25 쉬어러 피터 알. 쿠니츠(kunitz) 타입 프로테아제 억제 물질
US5786328A (en) 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
DE69632435T2 (de) 1995-07-24 2005-05-12 Mitsubishi Chemical Corp. Inhibitor des Hepatozytwachstumsfaktoraktivators
US5736364A (en) 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
JP3469584B2 (ja) 1996-03-11 2003-11-25 バイエル コーポレイション ヒト ビクニン
JP2001504709A (ja) 1997-01-31 2001-04-10 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 組織因子経路インヒビター３
US6294648B1 (en) * 1999-07-20 2001-09-25 Bayer Corporation Protein having proteinase inhibitor activity

Similar Documents

Publication Publication Date Title
JP2004000208A5 (https=)
JP3469584B2 (ja) ヒト ビクニン
DK171824B1 (da) Blodkoagulationsinhiberende hirudinderivater, fremgangsmåde til deres udvinding, deres anvendelse samt middel indeholdende dem
JP2004525097A5 (https=)
KR20170123640A (ko) 면역조절제로서의 1,2,4-옥사다이아졸 및 티아다이아졸 화합물
KR20170123680A (ko) 면역조절제로서의 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
JPH08509735A (ja) トロンビン阻害剤
JP2001519358A (ja) ジペプチドのアポトーシスインヒビターおよびそれらの使用
JP2004143182A (ja) インターロイキン−１β変換酵素のインヒビター
HU230773B1 (hu) Benzamidok és rokon Xa faktor inhibitorok
MXPA01010114A (es) Inhibidores de peso molecular bajo de las proteasas complemento.
US10351594B2 (en) Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
JP2018520707A (ja) 新規なトリプシンアイソフォームおよびそれらの使用
JP7606966B2 (ja) ミトコンドリア病を標的とするアナログ
JP7018075B2 (ja) メトトレキサートとペプチドの結合体
JP6860877B2 (ja) 骨芽細胞の分化促進剤および骨形成促進剤
KR20090009796A (ko) 키메라 쿠니츠 도메인 및 그의 용도
BG108587A (bg) Пептиди притежаващи анти -ангиогенна активност
CA2310677C (en) In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
JPH0625288A (ja) ペプチドまたはその塩
JP3893579B2 (ja) 新規なテトラペプチドおよびアンジオテンシン変換酵素阻害剤
CN103370331B (zh) 用于治疗关节病的氨基他汀衍生物
US11492390B2 (en) Mutant alpha-1-antitrypsin compositions and use thereof
JPH06220088A (ja) アンジオテンシンｉ変換酵素を阻害するトリペプチドおよびその製造法ならびにそれを含む食品
RU98118678A (ru) Бикунин человека